Dr. Coleman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
360 E 4500
Ste 4
Salt Lake City, UT 84107Phone+1 801-266-0055
Education & Training
- Duke University HospitalFellowship, Dermatopathology, 2002 - 2003
- University of Utah HealthResidency, Pathology-Anatomic and Clinical, 1997 - 2002
- University of Utah School of MedicineClass of 1997
- Brigham Young UniversityB.S., Business Management, Magna Cum Laude, 1987 - 1993
Certifications & Licensure
- UT State Medical License 1998 - 2026
- ID State Medical License 2008 - 2025
- MO State Medical License 2015 - 2025
- MT State Medical License 2007 - 2010
- NC State Medical License 2002 - 2003
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Dermatopathology
Awards, Honors, & Recognition
- William Bradford Teaching Award, Department of Pathology Duke University Medical Center, 2003
- Physician-in-Training Award, Best Poster Abstract Presentation American Society of Dermatopathology, 2002
- Best Resident Abstract/ Platform Presentation Award, G.I. Section USCAP, 2001
- Join now to see all
Publications & Presentations
PubMed
- 329 citationsMicrosatellite Instability in Sporadic Colon Cancer Is Associated with an Improved Prognosis at the Population LevelWade S. Samowitz, Karen Curtin, Khe-Ni Ma, Donna M. Schaffer, Landon W. Coleman
Cancer Epidemiology, Biomarkers & Prevention. 2001-09-01 - 20 citationsPrimary cutaneous perivascular epithelioid cell tumor (PEComa): Five new cases and review of the literature.Lauren N. Stuart, Russell G. Tipton, Michael R. DeWall, Douglas C. Parker, Christina D. Stelton
Journal of Cutaneous Pathology. 2017-08-01 - 15 citationsImmunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas.Landon W. Coleman, Igor B. Bronstein, Joseph A. Holden
Anticancer Research. 2001-03-01
Journal Articles
- Autopsy-Proven, Sporadic Pick’s Disease with Onset at Age 25Coleman LW, Digre KB, Stephenson GM, and Townsend JJ, Arch Neurol, 1/1/2002
- Human DNA Topoisomerase I: An Anticancer Drug Target Present in Human SarcomasColeman LW, Rohr LR, and Holden JA, Hum Pathol, 1/1/2002
- Microsatellite Instability in Sporadic Colon Cancer is Associated with an Improved Prognosis at the Population LevelSamowitz WS, Curtin K, Schaffer D, Coleman LW, Leppert M, and Slattery ML, Cancer Epidemiol Biomarkers Prev, 1/1/2001
- Join now to see all
Abstracts/Posters
- Abnormalities of Chromosome 7 in Thin Lethal Melanomas by Fluorescence in Situ Hybridization on Paraffin-Embedded Material.Coleman LW, Herman CM, Goodman BK, Madden JF, Golembiewski-Ruiz VA, Molino AC, Tirado CA, Grichnik JM, and Selim MA, American Society of Dermatopathology 39th Annual Meeting, Phoenix, AZ, 1/1/2002
- Abnormalities of Chromosome 7 are Common in Thin Lethal Melanomas by Fluorescence in Situ Hybridization on Paraffin-Embedded Material.Coleman LW, Goodman BK, Herman CM, Madden JF, Golembiewski-Ruiz VA, Tirado CA, Grichnik JM, Molino AC, and Selim MA, American J Dermatopathol, 1/1/2002
- Immunohistochemical Staining for DNA Topoisomerase I, DNA Topoisomerase II-alpha, and p53 in Human Soft Tissue Sarcomas.Coleman LW, Rohr LR, and Holden JA, United States and Canadian Academy of Pathology Annual Meeting, Atlanta, GA, 1/1/2001
- Join now to see all
Lectures
- Microsatellite Instability in Sporadic Colon Cancer is Associated with an Improved Prognosis at the Population Level.Atlanta, GA - 1/1/2001
- Analytical Performance of a Troponin I Assay.Salt Lake City, UT - 1/1/2000
- Expression of DNA Topoisomerase I and DNA Topoisomerase II-Alpha in Testicular Seminomas.Salt Lake City, UT - 1/1/2000
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: